Financing opportunities from China: targeting investors and shaping deals
Join us for the second meeting of the China SIG, where we will gain practical advice around obtaining investment from China, and hear some shared experiences from those who have done it before.
The China Biotech SIG has been set up with the China-Britain Business Council (CBBC), and supported by the Department for International Trade (DIT), to provide a discussion platform for BIA and CBBC members in the Biotech sector, exploring the opportunities for business growth in and with China, via trade and investment.
The group is open to BIA and CBBC members only. The event is free of charge, however please register as there is limited capacity.
Arnold and Porter
International Financial Centre
25 Old Broad St
Lincoln Tsang, Arnold and Porter
Practical advice around investment from China
15.40 China Capital Market and the Chinese perspective
Joyce Xie, IP Capital, IP Group
15.55 How to send the right message in China
Tim Watson, Associate Partner, Instinctif Partners
Lessons learned from deals made
16.10 Strategic agreements and collaboration
Jonathan Tobin, Investment Director, Arix Bioscience
16.25 Chinese investment for drug development
Neil Clark, CEO, Destiny Pharma
Discussion and Q&A
16.40 Q&A with all the speakers
17.00 Drinks and networking